Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer

Journal of Virology

Volumn 82, Issue 20, 2008, Pages 9964-9977

  Kim, Sanggu ^a   Kim, Namshin ^a,c   Dong, Beihua ^b   Boren, David ^a   Lee, Serena A ^a   Das Gupta, Jaydip ^b   Gaughan, Christina ^b   Klein, Eric A ^b   Lee, Christopher ^a   Silverman, Robert H ^b   Chow, Samson A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; MICRORNA; PPPA(2'P5'A)N DEPENDENT RIBONUCLEASE; PPPA(2'P5'A)N-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

ACUTE DISEASE; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CARCINOGENIC ACTIVITY; CHROMOSOME; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA INTEGRATION; GENE INSERTION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; MALE; MURINE LEUKEMIA VIRUS; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CELL DU145; PROTO ONCOGENE; RETROVIRUS; RETROVIRUS INFECTION; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; VIRUS INFECTION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; XENOTROPIC VIRUS; ANIMAL; CELL LINE; CHROMOSOME MAP; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PROSTATE TUMOR; REGULATORY SEQUENCE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; MURINE LEUKEMIA VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

ANIMALS; CELL LINE; CHROMOSOME MAPPING; CPG ISLANDS; ENDORIBONUCLEASES; GAMMARETROVIRUS; HUMANS; LEUKEMIA VIRUS, MURINE; MALE; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; REGULATORY SEQUENCES, NUCLEIC ACID; RETROVIRIDAE INFECTIONS; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 53749107062     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01299-08     Document Type: Article

References (113)

1. Akagi, K., T. Suzuki, R. M. Stephens, N. A. Jenkins, and N. G. Copeland. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32:D523-D527.
2. Albertson, D. G., C. Collins, F. McCormick, and J. W. Gray. 2003. Chromosome aberrations in solid tumors. Nat. Genet. 34:369-376.
3. An, D. S., S. K. Kung, A. Bonifacino, R. P. Wersto, M. E. Metzger, B. A. Agricola, S. H. Mao, I. S. Chen, and R. E. Donahue. 2001. Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J. Virol. 75:3547-3555.
4. Appa, R. S., C. G. Shin, P. Lee, and S. A. Chow. 2001. Role of the nonspecific DNA-binding region and alpha helices within the core domain of retroviral integrase in selecting target DNA sites for integration. J. Biol. Chem. 276:45848-45855.
5. Barr, S. D., J. Leipzig, P. Shinn, J. R. Ecker, and F. D. Bushman. 2005. Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol. 79:12035-12044.
6. Berry, C., S. Hannenhalli, J. Leipzig, and F. D. Bushman. 2006. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2:e157.
7. Bester, A. C., M. Schwartz, M. Schmidt, A. Garrigue, S. Hacein-Bey-Abina, M. Cavazzana-Calvo, N. Ben-Porat, C. Von Kalle, A. Fischer, and B. Kerem. 2006. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther. 13:1057-1059.
8. Bhowmick, N. A., E. G. Neilson, and H. L. Moses. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337.
9. Bird, A. P. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
10. Bonilla, C., T. Mason, L. Long, C. Ahaghotu, W. Chen, A. Zhao, A. Coulibaly, F. Bennett, W. Aiken, T. Tullock, K. Coard, V. Freeman, and R. A. Kittles. 2006. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. Prostate 66:546-556.
11. Bor, Y.-C., M. D. Miller, F. D. Bushman, and L. E. Orgel. 1996. Target-sequence preferences of HIV-1 integration complexes in vitro. Virology 222:283-288.
12. Brown, P. O. 1997. Integration, p. 161-203. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6:857-866.
14. Calin, G. A., C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C. M. Croce. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101:2999-3004.
15. Carpten, J., N. Nupponen, S. Isaacs, R. Sood, C. Robbins, J. Xu, M. Faruque, T. Moses, C. Ewing, E. Gillanders, P. Hu, P. Bujnovszky, I. Makalowska, A. Baffoe-Bonnie, D. Faith, J. Smith, D. Stephan, K. Wiley, M. Brownstein, D. Gildea, B. Kelly, R. Jenkins, G. Hostetter, M. Matikainen, J. Schleutker, K. Klinger, T. Connors, Y. Xiang, Z. Wang, A. De Marzo, N. Papadopoulos, O. P. Kallioniemi, R. Burk, D. Meyers, H. Gronberg, P. Meltzer, R. Silverman, J. Bailey-Wilson, P. Walsh, W. Isaacs, and J. Trent. 2002. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat. Genet. 30:181-184.
16. Carter, B. S., T. H. Beaty, G. D. Steinberg, B. Childs, and P. C. Walsh. 1992. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA 89:3367-3371.
17. Casey, G., P. J. Neville, S. J. Plummer, Y. Xiang, L. M. Krumroy, E. A. Klein, W. J. Catalona, N. Nupponen, J. D. Carpten, J. M. Trent, R. H. Silverman, and J. S. Witte. 2002. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat. Genet. 32:581-583.
18. Chan, J. A., A. M. Krichevsky, and K. S. Kosik. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:6029-6033.
19. Chen, H., W. Hernandez, M. D. Shriver, C. A. Ahaghotu, and R. A. Kittles. 2006. ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum. Genet. 120:69-76.
20. Cheng, C. K., L. W. Chow, W. T. Loo, T. K. Chan, and V. Chan. 2005. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res. 65:8646-8654.
21. Ciuffi, A., M. Llano, E. Poeschla, C. Hoffmann, J. Leipzig, P. Shinn, J. R. Ecker, and F. Bushman. 2005. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11:1287-1289.
22. Cohen, A., M. Shmoish, L. Levi, U. Cheruti, B. Levavi-Sivan, and E. Lubzens. 2008. Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 149:1687-1696.
23. Crawford, G. E., I. E. Holt, J. C. Mullikin, D. Tai, R. Blakesley, G. Bouffard, A. Young, C. Masiello, E. D. Green, T. G. Wolfsberg, and F. S. Collins. 2004. Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc. Natl. Acad. Sci. USA 101:992-997.
24. Crawford, G. E., I. E. Holt, J. Whittle, B. D. Webb, D. Tai, S. Davis, E. H. Margulies, Y. Chen, J. A. Bernat, D. Ginsburg, D. Zhou, S. Luo, T. J. Vasicek, M. J. Daly, T. G. Wolfsberg, and F. S. Collins. 2006. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 16:123-131.
25. Crise, B., Y. Li, C. Yuan, D. R. Morcock, D. Whitby, D. J. Munroe, L. O. Arthur, and X. Wu. 2005. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79:12199-12204.
26. De Marzo, A. M., E. A. Platz, S. Sutcliffe, J. Xu, H. Gronberg, C. G. Drake, Y. Nakai, W. B. Isaacs, and W. G. Nelson. 2007. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7:256-269.
27. Derse, D., B. Crise, Y. Li, G. Princler, N. Lum, C. Stewart, C. F. McGrath, S. H. Hughes, D. J. Munroe, and X. Wu. 2007. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J. Virol. 81:6731-6741.
28. Dong, B., S. Kim, S. Hong, J. Das Gupta, K. Malathi, E. A. Klein, D. Ganem, J. L. Derisi, S. A. Chow, and R. H. Silverman. 2007. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. USA 104:1655-1660.
29. Dong, J. T. 2001. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 20:173-193.
30. Durkin, S. G., and T. W. Glover. 2007. Chromosome fragile sites. Annu. Rev. Genet. 41:169-192.
31. Elgin, S. C. 1988. The formation and function of DNase I hypersensitive sites in the process of gene activation. J. Biol. Chem. 263:19259-19262.
32. Esquela-Kerscher, A., and F. J. Slack. 2006. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269.
33. Fan, H., M. Palmarini, and J. C. DeMartini. 2003. Transformation and oncogenesis by jaagsiekte sheep retrovirus. Curr. Top. Microbiol. Immunol. 275:139-177.
34. Faschinger, A., F. Rouault, J. Sollner, A. Lukas, B. Salmons, W. H. Gunzburg, and S. Indik. 2008. Mouse mammary tumor virus integration site selection in human and mouse genomes. J. Virol. 82:1360-1367.
35. Feitelson, M. A., and J. Lee. 2007. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 252:157-170.
36. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256.
37. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
38. Hacker, C. V., C. A. Vink, T. W. Wardell, S. Lee, P. Treasure, S. M. Kingsman, K. A. Mitrophanous, and J. E. Miskin. 2006. The integration profile of EIAV-based vectors. Mol. Ther. 14:536-545.
39. Hanlon, L., N. I. Barr, K. Blyth, M. Stewart, P. Haviernik, L. Wolff, K. Weston, E. R. Cameron, and J. C. Neil. 2003. Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro. J. Virol. 77:1059-1068.
40. Harper, A. L., M. Sudol, and M. Katzman. 2003. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J. Virol. 77:3838-3845.
41. Hematti, P., B. K. Hong, C. Ferguson, R. Adler, H. Hanawa, S. Sellers, I. E. Holt, C. E. Eckfeldt, Y. Sharma, M. Schmidt, C. von Kalle, D. A. Persons, E. M. Billings, C. M. Verfaillie, A. W. Nienhuis, T. G. Wolfsberg, C. E. Dunbar, and B. Calmels. 2004. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2:e423.
42. Ishikawa, K., and H. Mizusawa. 2006. On autosomal dominant cerebellar ataxia (ADCA) other than polyglutamine diseases, with special reference to chromosome 16q22.1-linked ADCA. Neuropathology 26:352-360.
43. Jemal, A., T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun. 2005. Cancer statistics, 2005. CA Cancer J. Clin. 55:10-30.
44. Kammerer, S., R. B. Roth, R. Reneland, G. Marnellos, C. R. Hoyal, N. J. Markward, F. Ebner, M. Kiechle, U. Schwarz-Boeger, L. R. Griffiths, C. Ulbrich, K. Chrobok, G. Forster, G. M. Praetorius, P. Meyer, J. Rehbock, C. R. Cantor, M. R. Nelson, and A. Braun. 2004. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 64:8906-8910.
45. Kang, Y., C. J. Moressi, T. E. Scheetz, L. Xie, D. T. Tran, T. L. Casavant, P. Ak, C. J. Benham, B. L. Davidson, and P. B. McCray, Jr. 2006. Integration site choice of a feline immunodeficiency virus vector. J. Virol. 80:8820-8823.
46. Kao, C., S. Q. Wu, S. DeVries, W. S. Reznikoff, F. M. Waldman, and C. A. Reznikoff. 1993. Carcinogen-induced amplification of SV40 DNA inserted at 9q12-21.1 associated with chromosome breakage, deletions, and translocations in human uroepithelial cell transformation in vitro. Genes Chromosomes Cancer 8:155-166.
47. Katso, R. M., O. E. Pardo, A. Palamidessi, C. M. Franz, M. Marinov, A. De Laurentiis, J. Downward, G. Scita, A. J. Ridley, M. D. Waterfield, and A. Arcaro. 2006. Phosphoinositide 3-kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol. Biol. Cell 17:3729-3744.
48. Kim, S., Y. Kim, T. Liang, J. S. Sinsheimer, and S. A. Chow. 2006. A high-throughput method for cloning and sequencing human immunodeficiency virus type 1 integration sites. J. Virol. 80:11313-11321.
49. Kline-Smith, S. L., S. Sandall, and A. Desai. 2005. Kinetochore-spindle microtubule interactions during mitosis. Curr. Opin. Cell Biol. 17:35-46.
50. Knutsen, T., V. Gobu, R. Knaus, H. Padilla-Nash, M. Augustus, R. L. Strausberg, I. R. Kirsch, K. Sirotkin, and T. Ried. 2005. The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer 44:52-64.
51. Kuivenhoven, J. A., H. Pritchard, J. Hill, J. Frohlich, G. Assmann, and J. Kastelein. 1997. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38:191-205.
52. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
53. Laprise, P., A. Viel, and N. Rivard. 2004. Human homolog of disc-large is required for adherens junction assembly and differentiation of human intestinal epithelial cells. J. Biol. Chem. 279:10157-10166.
54. Larsen, F., G. Gundersen, R. Lopez, and H. Prydz. 1992. CpG islands as gene markers in the human genome. Genomics 13:1095-1107.
55. Laufs, S., K. Z. Nagy, F. A. Giordano, A. Hotz-Wagenblatt, W. J. Zeller, and S. Fruehauf. 2004. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns. Mol. Ther. 10:874-881.
56. Lazo, P. A., J. S. Lee, and P. N. Tsichlis. 1990. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc. Natl. Acad. Sci. USA 87:170-173.
57. Lehen'kyi, V., M. Flourakis, R. Skryma, and N. Prevarskaya. 2007. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 26:7380-7385.
58. Lewinski, M. K., M. Yamashita, M. Emerman, A. Ciuffi, H. Marshall, G. Crawford, F. Collins, P. Shinn, J. Leipzig, S. Hannenhalli, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2006. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2:e60.
59. Lin, H. K., Y. C. Hu, L. Yang, S. Altuwaijri, Y. T. Chen, H. Y. Kang, and C. Chang. 2003. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. J. Biol. Chem. 278:50902- 50907.
60. Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
61. Maier, C., J. Haeusler, K. Herkommer, Z. Vesovic, J. Hoegel, W. Vogel, and T. Paiss. 2005. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br. J. Cancer 92:1159-1164.
62. Mattie, M. D., C. C. Benz, J. Bowers, K. Sensinger, L. Wong, G. K. Scott, V. Fedele, D. Ginzinger, R. Getts, and C. Haqq. 2006. Optimized highthroughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 5:24.
63. Memarzadeh, S., L. Xin, D. J. Mulholland, A. Mansukhani, H. Wu, M. A. Teitell, and O. N. Witte. 2007. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12:572-585.
64. Meng, F., R. Henson, H. Wehbe-Janek, K. Ghoshal, S. T. Jacob, and T. Patel. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658.
65. Mikkers, H., and A. Berns. 2003. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88:53-99.
66. Miller, D. G., L. M. Petek, and D. W. Russell. 2004. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36:767-773.
67. Mitchell, R. S., B. F. Beitzel, A. R. Schroder, P. Shinn, H. Chen, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:e234.
68. Mitelman, F., B. Johansson, and F. Mertens. 2007. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 7:233-245.
69. Moalic, Y., Y. Blanchard, H. Felix, and A. Jestin. 2006. Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J. Virol. 80:10980-10988.
70. Montini, E., D. Cesana, M. Schmidt, F. Sanvito, M. Ponzoni, C. Bartholomae, L. Sergi Sergi, F. Benedicenti, A. Ambrosi, C. Di Serio, C. Doglioni, C. von Kalle, and L. Naldini. 2006. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24:687-696.
71. Narezkina, A., K. D. Taganov, S. Litwin, R. Stoyanova, J. Hayashi, C. Seeger, A. M. Skalka, and R. A. Katz. 2004. Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 78:11656-11663.
72. Nelson, W. G., A. M. De Marzo, and W. B. Isaacs. 2003. Prostate cancer. N. Engl. J. Med. 349:366-381.
73. Nowrouzi, A., M. Dittrich, C. Klanke, M. Heinkelein, M. Rammling, T. Dandekar, C. von Kalle, and A. Rethwilm. 2006. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87:1339-1347.
74. Orr-Urtreger, A., A. Bar-Shira, D. Bercovich, N. Matarasso, U. Rozovsky, S. Rosner, S. Soloviov, G. Rennert, L. Kadouri, A. Hubert, H. Rennert, and H. Matzkin. 2006. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol. Biomarkers Prev. 15:474-479.
75. Pagano, J. S., M. Blaser, M. A. Buendia, B. Damania, K. Khalili, N. Raab-Traub, and B. Roizman. 2004. Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol. 14:453-471.
76. Pett, M., and N. Coleman. 2007. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J. Pathol. 212:356-367.
77. Popescu, N. C. 2003. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett. 192:1-17.
78. Porkka, K. P., M. J. Pfeiffer, K. K. Waltering, R. L. Vessella, T. L. Tammela, and T. Visakorpi. 2007. MicroRNA expression profiling in prostate cancer. Cancer Res. 67:6130-6135.
79. Pruitt, K. D., K. S. Katz, H. Sicotte, and D. R. Maglott. 2000. Introducing RefSeq and LocusLink: curated human genome resources at the NCBI. Trends Genet. 16:44-47.
80. Rennert, H., D. Bercovich, A. Hubert, D. Abeliovich, U. Rozovsky, A. Bar-Shira, S. Soloviov, L. Schreiber, H. Matzkin, G. Rennert, L. Kadouri, T. Peretz, Y. Yaron, and A. Orr-Urtreger. 2002. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am. J. Hum. Genet. 71:981-984.
81. Rohdewohld, H., H. Weiher, W. Reik, R. Jaenisch, and M. Breindl. 1987. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J. Virol. 61:336-343.
82. Rokman, A., T. Ikonen, E. H. Seppala, N. Nupponen, V. Autio, N. Mononen, J. Bailey-Wilson, J. Trent, J. Carpten, M. P. Matikainen, P. A. Koivisto, T. L. Tammela, O. P. Kallioniemi, and J. Schleutker. 2002. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am. J. Hum. Genet. 70:1299-1304.
83. Rosenberg, N., and P. Jolicoeur. 1997. Retroviral pathogenesis, p. 475-586. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
84. Ross, T. M., S. M. Pettiford, and P. L. Green. 1996. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
85. Sauvageau, M., M. D. Miller, S. Lemieux, J. Lessard, J. Hebert, and G. Sauvageau. 2008. Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood 111:790-799.
86. Schroder, A. R., P. Shinn, H. Chen, C. Berry, J. R. Ecker, and F. Bushman. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529.
87. Schwartz, M., E. Zlotorynski, and B. Kerem. 2006. The molecular basis of common and rare fragile sites. Cancer Lett. 232:13-26.
88. Seggewiss, R., S. Pittaluga, R. L. Adler, F. J. Guenaga, C. Ferguson, I. H. Pilz, B. Ryu, B. P. Sorrentino, W. S. Young III, R. E. Donahue, C. von Kalle, A. W. Nienhuis, and C. E. Dunbar. 2006. Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque. Blood 107:3865-3867.
89. Shook, S. J., J. Beuten, K. C. Torkko, T. L. Johnson-Pais, D. A. Troyer, I. M. Thompson, and R. J. Leach. 2007. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin. Cancer Res. 13:5959-5964.
90. Shun, M. C., N. K. Raghavendra, N. Vandegraaff, J. E. Daigle, S. Hughes, P. Kellam, P. Cherepanov, and A. Engelman. 2007. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 21:1767-1778.
91. Silverman, R. H. 2003. Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812.
92. Simpson, M. A. 2006. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am. J. Pathol. 169:247-257.
93. Simpson, M. A., C. M. Wilson, and J. B. McCarthy. 2002. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am. J. Pathol. 161:849-857.
94. Smith, J. R., D. Freije, J. D. Carpten, H. Gronberg, J. Xu, S. D. Isaacs, M. J. Brownstein, G. S. Bova, H. Guo, P. Bujnovszky, D. R. Nusskern, J. E. Damber, A. Bergh, M. Emanuelsson, O. P. Kallioniemi, J. Walker-Daniels, J. E. Bailey-Wilson, T. H. Beaty, D. A. Meyers, P. C. Walsh, F. S. Collins, J. M. Trent, and W. B. Isaacs. 1996. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374.
95. Sprecher, E., R. Bergman, G. Richard, R. Lurie, S. Shalev, D. Petronius, A. Shalata, Y. Anbinder, R. Leibu, I. Perlman, N. Cohen, and R. Szargel. 2001. Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin. Nat. Genet. 29:134-136.
96. Sun, M., L. Ma, L. Xu, J. Li, W. Zhang, G. Petrovics, M. Makarem, I. Sesterhenn, M. Zhang, E. J. Blanchette-Mackie, J. Moul, S. Srivastava, and Z. Zou. 2002. A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumors. Mol. Med. 8:655-663.
97. Sutherland, G. R. 2003. Rare fragile sites. Cytogenet. Genome Res. 100: 77-84.
98. Tavazoie, S. F., C. Alarcon, T. Oskarsson, D. Padua, Q. Wang, P. D. Bos, W. L. Gerald, and J. Massague. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152.
99. Toledo, F., and G. M. Wahl. 2006. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6:909-923.
100. Trobridge, G. D., D. G. Miller, M. A. Jacobs, J. M. Allen, H. P. Kiem, R. Kaul, and D. W. Russell. 2006. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 103:1498-1503.
101. Urisman, A., R. J. Molinaro, N. Fischer, S. J. Plummer, G. Casey, E. A. Klein, K. Malathi, C. Magi-Galluzzi, R. R. Tubbs, D. Ganem, R. H. Silverman, and J. L. DeRisi. 2006. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2:e25.
102. Vijaya, S., D. L. Steffen, and H. L. Robinson. 1986. Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J. Virol. 60:683-692.
103. Volinia, S., G. A. Calin, C.-G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C. C. Harris, and C. M. Croce. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103:2257-2261.
104. Wang, G. P., A. Ciuffi, J. Leipzig, C. C. Berry, and F. D. Bushman. 2007. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17:1186-1194.
105. Wentzensen, N., S. Vinokurova, and M. von Knebel Doeberitz. 2004. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64:3878-3884.
106. Wiklund, F., B. A. Jonsson, A. J. Brookes, L. Stromqvist, J. Adolfsson, M. Emanuelsson, H. O. Adami, K. Augustsson-Balter, and H. Gronberg. 2004. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin. Cancer Res. 10:7150-7156.
107. Wu, D., H. E. Zhau, W. C. Huang, S. Iqbal, F. K. Habib, O. Sartor, L. Cvitanovic, F. F. Marshall, Z. Xu, and L. W. Chung. 2007. cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 26:5070-5077.
108. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.
109. Xiang, Y., Z. Wang, J. Murakami, S. Plummer, E. A. Klein, J. D. Carpten, J. M. Trent, W. B. Isaacs, G. Casey, and R. H. Silverman. 2003. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates. Cancer Res. 63:6795-6801.
110. Zhang, L., J. Huang, N. Yang, J. Greshock, M. S. Megraw, A. Giannakakis, S. Liang, T. L. Naylor, A. Barchetti, M. R. Ward, G. Yao, A. Medina, A. O'Brien-Jenkins, D. Katsaros, A. Hatzigeorgiou, P. A. Gimotty, B. L. Weber, and G. Coukos. 2006. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 103:9136-9141.
111. Zhang, Y., Y. Yang, S. Yeh, and C. Chang. 2004. ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation. Mol. Cell. Biol. 24:1044-1057.
112. Zhou, A., B. A. Hassel, and R. H. Silverman. 1993. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765.
113. Zlotorynski, E., A. Rahat, J. Skaug, N. Ben-Porat, E. Ozeri, R. Hershberg, A. Levi, S. W. Scherer, H. Margalit, and B. Kerem. 2003. Molecular basis for expression of common and rare fragile sites. Mol. Cell. Biol. 23:7143-7151.